<DOC>
	<DOCNO>NCT02188589</DOCNO>
	<brief_summary>To evaluate safety feasibility INEX Nasal Implant subject moderate severe nasal valve collapse .</brief_summary>
	<brief_title>Evaluation Absorbable Implant Treatment Nasal Valve Collapse</brief_title>
	<detailed_description>This study Multi-Center , Non-Randomized , Prospective Exploratory Study INEX Nasal Implant . The purpose study evaluate safety feasibility INEX Nasal Implant subject moderate severe nasal valve collapse .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<criteria>1 ) The subject ≥ 18 year age . 2 ) The subject willing able provide inform consent . 3 ) The subject willing able comply study protocol . 4 ) The subject seek treatment nasal obstruction one side nose willing undergo officebased intraoperative nasal implant procedure lieu alternative treatment ( i.e. , surgical repair use external dilator ) . 5 ) The subject baseline NOSE Score ≥ 11 . 6 ) The subject agree followup examination 18 month post treatment . 7 ) The investigator determine nasal valve collapse ( NVC ) primary significant contributor subject 's nasal obstruction base clinical presentation , physical examination nasal endoscopy . 8 ) Patient agree mupirocin ointment prior implantation . 9 ) The subject sufficient space available receive implant shape maxilla allow appropriate anchor location . 10 ) The subject offer available treatment decline treatment . 1 ) The subject concomitant surgical nonsurgical treatment nasal valve subject prior rhinoplasty within 12 month . 2 ) The subject septoplasty , inferior turbinate reduction surgical nasal procedure within past six ( 6 ) month . 3 ) The subject recurrent methicillinresistant Staphylococcus aureas ( MRSA ) infection current Staphylococcus infection . 4 ) The subject plan concomitant surgical nonsurgical treatment nasal valve within 6 month study ( 6 month followup ) . 5 ) The subject use plan use intranasal steroid treatment ( within 2 week preimplant 2 week post implantation ) . 6 ) The subject permanent implant , dilator and/or use external device nasal area . 7 ) The subject concomitant inflammatory infectious skin condition unhealed wound treatment area . 8 ) The subject cancerous precancerous lesion and/or radiation exposure treatment area chemotherapy within 24 month study . 9 ) The subject know suspected allergy contraindication general local anesthetic agent / antibiotic medication . 10 ) The subject history significant bleeding disorder . 11 ) The subject know suspected pregnant lactating . 12 ) The subject know suspect allergy PLA bioresorbable material . 13 ) The subject significant systemic disease chronic steroid use poorly control diabetes investigator 's opinion could predispose subject poor wound healing . 14 ) The subject currently use nasal oxygen CPAP . 15 ) The subject candidate procedure conduct general anesthesia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>